Cargando…
Fibroblast growth factor receptor 1-bound extracellular vesicle as novel therapy for osteoarthritis
Osteoarthritis (OA) is a joint condition that causes significant impairment of the chondrocyte. The gradual degradation of the cartilage lining of one or more freely moving joints, as well as persistent inflammation, are the causes of osteoarthritis. Current medications focus on alleviating symptoms...
Autores principales: | de Liyis, Bryan Gervais, Nolan, John, Maharjana, Made Agus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
China Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236721/ https://www.ncbi.nlm.nih.gov/pubmed/35836973 http://dx.doi.org/10.37796/2211-8039.1308 |
Ejemplares similares
-
Fibroblast growth factor-2 bound to specific dermal fibroblast-derived extracellular vesicles is protected from degradation
por: Petit, Isabelle, et al.
Publicado: (2022) -
Extracellular Vesicles and Autophagy in Osteoarthritis
por: Gao, Tianyang, et al.
Publicado: (2016) -
Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells
Publicado: (1988) -
Anti-high mobility group box protein 1 monoclonal antibody downregulating P-glycoprotein as novel epilepsy therapeutics
por: de Liyis, Bryan Gervais, et al.
Publicado: (2022) -
Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis
por: Withrow, Joseph, et al.
Publicado: (2016)